“It would be foolhardy for anyone to assume that we’ve lost interest in drugs.”
That is how Medicare Coverage and Analysis Group Director Louis Jacques reacts to questions about the agency’s newly updated list...
CMS Proposed National Coverage Decision Topic List Exempts Biopharma
The Centers for Medicare & Medicaid Services’ new list of “potential” topics for National Coverage Decisions includes 33 separate ideas, most proposed by the public. Not one is directly related to a biopharma topic. CMS’ coverage team swears it remains interested in drug-related coverage issues—but still, this is one list it is nice not to be on.